Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHEDRE Trial Protocol - Observational Study of the Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and Analgesics in the French Sickle-cell Disease Population

NCT02580565 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02580565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02580565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHEDRE Trial Protocol - Observational Study of the Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and Analgesics in the French Sickle-cell Disease Population
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
September 25, 2015
Completion date
December 31, 2017
Enrollment
1,004 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease